Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)

Tasly Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21,363	25,427	15,988	23,778	22,302	23,252
Market Cap Growth	-13.30%	59.04%	-32.76%	6.62%	-4.09%	-19.94%
Enterprise Value	18,535	24,806	15,103	23,396	23,975	30,193
Last Close Price	14.30	16.62	10.28	14.67	13.36	13.62
PE Ratio	20.78	23.19	-57.11	9.34	17.82	20.64
PS Ratio	2.46	2.93	1.85	2.99	1.64	1.22
PB Ratio	1.70	2.00	1.26	1.79	1.80	1.96
P/FCF Ratio	10.42	13.33	8.53	10.67	16.13	24.49
P/OCF Ratio	7.17	9.87	7.01	8.49	12.45	13.84
EV/Sales Ratio	2.14	2.86	1.75	2.94	1.77	1.59
EV/EBITDA Ratio	9.54	13.39	8.51	14.20	12.44	13.51
EV/EBIT Ratio	12.70	17.23	11.27	18.83	17.28	16.34
EV/FCF Ratio	9.04	13.01	8.05	10.49	17.34	31.80
Debt / Equity Ratio	0.21	0.22	0.17	0.13	0.23	0.69
Debt / EBITDA Ratio	1.37	1.46	1.17	0.98	1.45	3.65
Debt / FCF Ratio	1.30	1.48	1.16	0.76	2.02	8.59
Asset Turnover	0.50	0.52	0.52	0.48	0.67	0.77
Inventory Turnover	1.62	1.76	2.04	1.85	4.16	5.28
Quick Ratio	2.37	2.91	3.54	4.09	2.73	1.54
Current Ratio	2.95	3.69	4.31	4.99	3.26	1.91
Return on Equity (ROE)	7.75%	8.02%	-2.68%	18.74%	8.99%	8.70%
Return on Assets (ROA)	5.24%	5.42%	5.08%	4.70%	4.28%	4.70%
Return on Capital (ROIC)	5.83%	5.92%	5.61%	5.14%	4.93%	5.66%
Earnings Yield	4.81%	4.21%	-1.65%	9.92%	5.05%	4.31%
FCF Yield	9.59%	7.50%	11.73%	9.38%	6.20%	4.08%
Dividend Yield	3.64%	1.99%	3.21%	2.25%	2.47%	2.42%
Payout Ratio	53.79%	52.58%	-	25.88%	70.99%	90.23%
Buyback Yield / Dilution	-1.47%	-1.77%	2.29%	-0.08%	1.06%	-0.16%
Total Shareholder Return	2.16%	0.22%	5.50%	2.16%	3.53%	2.26%

Source: S&P Capital IQ. Standard template. Financial Sources.